BioSpace News Archive

Business

858 Therapeutics Expands Board of Directors and Leadership Team

858 Therapeutics today announced the strengthening of its board of directors and leadership team in preparation for its next stage of growth.

April 5, 2022
·
3 min read
Pharm Country

Oramed Granted NASH Patent in Europe

Oramed Pharmaceuticals Inc. today announced that the European Patent Office has granted the Company the patent titled “Methods and Compositions for Treating NAFLD, Hepatic Steatosis, and Sequelae Thereof.”

April 5, 2022
·
4 min read
Biotech Bay

Vaxcyte to Present at the 21st Annual Needham Virtual Healthcare Conference

Vaxcyte, Inc. today announced that Company management will participate in a fireside chat at the 21st Annual Needham Virtual Healthcare Conference on Tuesday, April 12, 2022 at 12:45 p.m. ET.

April 5, 2022
·
1 min read
Drug Development

Pharma Two B Presents Late-Breaker Abstract on Positive Efficacy and Safety Data of P2B001 from Phase 3 Trial at American Academy of Neurology (AAN) Annual Meeting

Pharma Two B Ltd today announced that the efficacy and safety data from its recently completed Phase 3, randomized controlled trial of P2B001 in the management of early Parkinson’s disease is being presented today, April 5th.

April 5, 2022
·
6 min read
Business

MindMed Appoints Francois Lilienthal, MD as Chief Commercial Officer

Mind Medicine today announced the appointment of Francois Lilienthal, MD as Chief Commercial Officer.

April 5, 2022
·
3 min read
Drug Development

Lakewood-Amedex Enrolls First Patient in Phase 2 Clinical Trial for Patients with Chronic Diabetic Foot Ulcers (cDFU)

Lakewood-Amedex, Inc. announced today that it has commenced its second Phase 2 study using Bisphosphocin Nu-3 antimicrobial in treating patients with diabetic foot ulcers (DFU).

April 5, 2022
·
4 min read
Business

ARS Pharmaceuticals Appoints Eric Karas as Chief Commercial Officer and Kathleen Scott as Chief Financial Officer

ARS Pharmaceuticals, Inc. today announced the expansion of its executive leadership team with the appointments of industry veterans, Eric Karas as chief commercial officer and Kathleen (Kathy) Scott as chief financial officer.

April 5, 2022
·
4 min read
Genetown

Axial Therapeutics’ Scientific Founder Sarkis Mazmanian, Ph.D., to Present Research Highlighting the Gut-Brain Connection in Autism Spectrum Disorder (ASD) at TACA’s Autism Action Conference

Axial Therapeutics today announced that its scientific founder and California Institute of Technology (Caltech) Professor, Sarkis Mazmanian, Ph.D., will be presenting at TACA’s Autism Action Conference, taking place virtually from April 8-9, 2022.

April 5, 2022
·
5 min read
Drug Development

Updated Preclinical Data Support Potential of First AAV-Based Gene Therapy as a Treatment for Adrenomyeloneuropathy

SwanBio Therapeutics today presented updated data from studies of the company’s lead candidate in non-human primates (NHPs) and rodent models.

April 5, 2022
·
6 min read
BioMidwest

Celcuity to Participate in Upcoming Needham and Canaccord Genuity Investor Conferences

Celcuity Inc. today announced that Brian Sullivan, Chairman, Chief Executive Officer, and Co-founder of Celcuity, will participate in the following virtual investor conferences: A company presentation at the 21st Annual Needham Healthcare Conference at 3:45 p.m. ET on Tuesday, April 12, 2022.

April 5, 2022
·
1 min read